Szeged, Hungary

Bela Ozsvari

USPTO Granted Patents = 1 


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bela Ozsvari: Innovator in Pharmaceutical Compounds

Introduction

Bela Ozsvari is a notable inventor based in Szeged, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on 8-hydroxy-quinoline derivatives. His inventions focus on compounds that have potential applications in treating neurological diseases and conditions associated with oxidative stress.

Latest Patents

Ozsvari holds 1 patent for his invention related to 8-hydroxy-quinoline derivatives. This invention pertains to compounds of the general formula (I) and their pharmaceutically acceptable salts. In this formula, R represents various groups, including hydrogen atoms, lower alkyl groups, lower alkenyl groups, lower cycloalkyl groups, aryl groups, aralkyl groups, or heterocyclic groups. These groups can be optionally substituted with electron-withdrawing or electron-donating groups, enhancing their medicinal properties.

Career Highlights

Throughout his career, Bela Ozsvari has worked with several companies, including Avidin Kutato, Fejleszto Es Kereskedelmi Korlatolt Felelossegu Tarsasag and Ubichem Kutato Korlatolt Felelossegu Tarsasag. His work in these organizations has contributed to the advancement of pharmaceutical research and development.

Collaborations

Ozsvari has collaborated with notable colleagues, including Laszlo Puskas and Csaba Szabo. These partnerships have fostered innovation and have been instrumental in the development of his patented compounds.

Conclusion

Bela Ozsvari's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work on 8-hydroxy-quinoline derivatives showcases the potential for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…